Anzeige
Mehr »
Login
Dienstag, 15.10.2024 Börsentäglich über 12.000 News von 675 internationalen Medien
Diese Fusion könnte der Katalysator sein, den Anleger brauchen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Medien-Archiv vom 13.06.2024

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
13.06.Valeo Pharma Inc.: Valeo Pharma Reports Record Second Quarter 2024 Revenues22Record Q2-24 revenues of $14.1 million, up 4% over Q2-23 outpacing revenue softness in several non-core brands Q2-24 adjusted EBITDA loss of $2.5 million compared to $1.7 million for Q2-23, up 48%...
► Artikel lesen
13.06.Timney launcht neuen Glock-Abzug-
13.06.Bundeswehr erhält 1.515 zusätzliche Militär-Transportfahrzeuge-
13.06.Neuer Kampfpanzer Leopard 2 A-RC 3.0-
13.06.Torsten Akmann neuer ziviler Vizepräsident des MAD-
13.06.Antycip mit 3D-Modellbibliothek für Luftfahrt und Verteidigung-
13.06.Sila Realty Trust, Inc. Begins Trading on the New York Stock Exchange108TAMPA, Fla.--(BUSINESS WIRE)--Sila Realty Trust, Inc. (NYSE: SILA) ("Sila", the "Company", "we" or "us"), a net lease real estate investment trust ("REIT") with a strategic investment focus on...
► Artikel lesen
13.06.Steuergünstig Schenken: Mit Nießbrauch Steuerlast senken und Erträge beziehen161Bei Schenkungen/Vererbungen fallen für die Begünstigten Steuern an. Mit dem Vorbehaltsnießbrauch bezieht der Schenkende weiterhin selbst die Erträge und senkt gleichzeitig die Schenkungs-Steuerlast....
► Artikel lesen
13.06.Sound Point Meridian Capital, Inc. Prices Initial Public Offering88NEW YORK--(BUSINESS WIRE)--Sound Point Meridian Capital, Inc. (NYSE: SPMC) (the "Company") today announced the pricing of its initial public offering of 4,000,000 shares of common stock at a public...
► Artikel lesen
13.06.McEwen Mining Inc. - S-4/A, Registration of securities, business combinations1
13.06.BRASKEM SA - 6-K, Report of foreign issuer4
13.06.HINES GLOBAL INCOME TRUST, INC. - 8-K, Current Report-
13.06.INNOVATIVE SOLUTIONS & SUPPORT INC - 8-K, Current Report-
13.06.AMMO, Inc. Reports Fourth Quarter and Fiscal Year 2024 Financial Results122SCOTTSDALE, Ariz., June 13, 2024 (GLOBE NEWSWIRE) -- AMMO, Inc. (Nasdaq: POWW, POWWP) ("AMMO" or the "Company"), the owner of GunBroker.com, the largest online marketplace serving the firearms and shooting...
► Artikel lesen
13.06.Enservco Corporation Provides Further Update on Plan to Regain Compliance with NYSE American Listing Standards146LONGMONT, Colo., June 13, 2024 (GLOBE NEWSWIRE) -- Enservco Corporation (NYSE American: ENSV) ("Enservco", or the "Company"), a diversified national provider of specialized well-site services to the...
► Artikel lesen
13.06.Amcomri Entertainment Inc.: Amcomri Announces Revocation of MCTO and Update on Q1 Filings185VANCOUVER, British Columbia, June 13, 2024 (GLOBE NEWSWIRE) -- Amcomri Entertainment Inc. ("Amcomri" or the "Company") (Cboe CA: AMEN) (Frankfurt: 25YO) (OTC: AMNNF) is pleased to announce, further...
► Artikel lesen
13.06.The Descartes Systems Group Inc.: Descartes Announces Results of Annual Meeting of Shareholders155WATERLOO, Ontario, June 13, 2024 (GLOBE NEWSWIRE) -- The Descartes Systems Group Inc. (the "Corporation") announced the voting results from its annual meeting of shareholders held on Thursday, June...
► Artikel lesen
13.06.Dyne Therapeutics, Inc.: Dyne Therapeutics Presents New Preclinical Data for its Facioscapulohumeral Muscular Dystrophy Program During the FSHD Society International Research Congress126- Leveraging the FORCE Platform, DYNE-302 Achieved Robust and Durable DUX4 Suppression and Functional Benefit in FSHD Preclinical Models - WALTHAM, Mass., June 13, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics...
► Artikel lesen
13.06.Enzo Biochem, Inc.: Enzo Biochem Reports Third Quarter Fiscal 2024 Results and Provides Business Update170FARMINGDALE, N.Y., June 13, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) ("Enzo" or the "Company") today announced financial results for the fiscal third quarter ended April 30, 2024. Third...
► Artikel lesen
13.06.Vaxart, Inc.: Vaxart Receives BARDA-Funded Project NextGen Award Valued Up to $453 Million to Conduct a Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate166- 10,000-subject Phase 2b study will evaluate Vaxart's next generation oral pill COVID-19 vaccine against an approved mRNA vaccine comparator - - Vaxart anticipates initiating enrollment as early...
► Artikel lesen
Seite:  Weiter >>